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The transcription factor T-bet (Tbox protein expressed in T cells) is
one of the master regulators of both the innate and adaptive
immune responses. It plays a central role in T-cell lineage commit-
ment, where it controls the TH1 response, and in gene regulation
in plasma B-cells and dendritic cells. T-bet is a member of the Tbox
family of transcription factors; however, T-bet coordinately regu-
lates the expression of many more genes than other Tbox pro-
teins. A central unresolved question is how T-bet is able to
simultaneously recognize distant Tbox binding sites, which may
be located thousands of base pairs away. We have determined
the crystal structure of the Tbox DNA binding domain (DBD) of
T-bet in complex with a palindromic DNA. The structure shows a
quaternary structure in which the T-bet dimer has its DNA binding
regions splayed far apart, making it impossible for a single dimer
to bind both sites of the DNA palindrome. In contrast to most
other Tbox proteins, a single T-bet DBD dimer binds simultaneously
to identical half-sites on two independent DNA. A fluorescence-
based assay confirms that T-bet dimers are able to bring two inde-
pendent DNA molecules into close juxtaposition. Furthermore,
chromosome conformation capture assays confirm that T-bet func-
tions in the direct formation of chromatin loops in vitro and in vivo.
The data are consistent with a looping/synapsing model for tran-
scriptional regulation by T-bet in which a single dimer of the tran-
scription factor can recognize and coalesce distinct genetic elements,
either a promoter plus a distant regulatory element, or promoters
on two different genes.
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master regulator
Transcription factors that control the expression of large fami-lies of genes involved in cell lineage commitment are often
termed master regulators of cell-fate determination (1). In the
development of both innate and adaptive immunity, one such
master regulator is the transcription factor T-bet (Tbox protein
expressed in T cells) (2). In T-cell–mediated adaptive immunity,
T-bet controls the differentiation of naive CD4+ T helper lym-
phocytes into TH1 cells by activating transcription of TH1-specific
genes, such as IFN-γ, while repressing transcription of TH2-
specific genes, such as IL-4 (3). CD4+ T cells lacking T-bet are
severely impaired in their ability to produce IFN-γ, susceptible
to Leishmania major infection, and have a marked in vivo shift
of the TH1/TH2 balance toward the TH2 pathway (4–6). Ectopic
expression of T-bet is sufficient to “reprogram” fully polarized
TH2 cells into the TH1 pathway, as demonstrated by induction
of IFN-γ transcription and shutdown of the expression of genes
encoding TH2 cytokines (7). T-bet–deficient and T-bet–over-
expressing strains of mice have provided confirming evidence
that T-bet is required for the generation of TH1 cells in vivo and
that it simultaneously represses IL-4 production and shuts down
the TH2 gene program (2). T-bet is required for the effective
handling of pathogens (6, 8) and cancer cells (9–11), is patho-
genic in the setting of autoimmunity (12), and is protective in
the asthmatic response (4). In addition to its roles in CD4+ cells
and the adaptive arm of the immune system, T-bet controls
the development and effector function of CD8+ cells (13–15) and
natural killer cells (16), is required for isotype switching to Ig G2a
in B cells (12), and also plays essential roles in dendritic and nat-
ural killer cell function in innate immunity (16, 17).
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T-bet belongs to the Tbox family of transcription regulators,
whose members are characterized by the presence of the Tbox
DNA binding domain (DBD). Tbox family proteins are required
both for early cell-fate decisions, such as those for formation of
the basic vertebrate body plan, and for differentiation and or-
ganogenesis (18). Tbox proteins are typically around 60 kDa in
molecular mass and comprise at least two structural and func-
tional domains: the Tbox sequence-specific DBD and a second
domain that is thought to be involved in interactions with other
proteins. The relative position of the domains varies between
different members of the family, but the order is conserved for
any one member and its orthologs. Despite sequence variations
within the Tbox DBD between family members, all members of
the family appear to bind to the same DNA consensus sequence,
TCACACCT. In several in vitro binding-site selection studies,
members of the Tbox family were found to bind preferentially
sequences containing two or more of these core motifs arranged
in various orientations; however, the significance of such double
sites in vivo is uncertain, as most Tbox target gene sites have
been found to contain only a single consensus motif (18).
To date, crystallographic analysis of Tbox proteins has been
reported only for the Tbox DBDs of Xbra, the Xenopus homolog
of the mammalian protein Brachyury (19), and the Tbox protein
TBX3 (20), both in complex with a palindromic consensus DNA
oligomer; and, more recently, Tbox protein TBX5 in both its
DNA-bound and unbound states (21) and TBX1 in its DNA-
bound state (22). The structures of all four Tbox domains in the
bound complexes are very similar (Fig. 1A), consisting of a seven-
stranded β-barrel domain that is closed by a smaller β-pleated
sheet, with two projecting helices that are involved in DNA
recognition. Although the monomers of Xbra, TBX3, and TBX1
differ little from one another, they do differ in the way they come
together on their two-site DNA duplexes. In the crystal structure,
Xbra binds as a dimer, and binding to each site appears to be
stabilized by monomer–monomer interactions. The dimer interface,
however, is not extensive, and it is likely that dimerization is an
artifact of crystallization coupled with the presence of a palindromic
DNA molecule. Consistent with this possibility, TBX3 and TBX1
have no dimer interface and recognize each site independently, al-

























Fig. 1. The Tbox transcription factors bind contig-
uous DNA elements. (A) Structures of the Tbox DBD–
DNA complexes of Xbra (PDB ID code 1XBR), TBX1
(PDB ID code 4A04), TBX3 (PDB ID code 1H6F), and
TBX5 (PDB ID code 2X6V). Note that the overall folds
of the four Tbox domains are essentially identical, as
is their mode of recognition of the B-form DNA
double helix. Xbra, TBX1, and TBX3 crystallized as
homodimers and bind two consensus target se-
quences, respectively, but the dimers are not tightly
associated and probably bind their two sites in-
dependently; TBX5 binds as a monomer to a single
site. (B) Models for action at a distance by a dimeric
transcription factor. The two subunits of the dimer
are shown in red and blue and may be either dif-
ferent (heterodimer) or identical (homodimer). In a
looping model, each subunit binds independently to
a promoter recognition element and a distant ele-
ment, which may be either another promoter or, as
shown, an enhancer sequence. Formation of the
dimer juxtaposes the distant sites. Tracking postu-
lates that the different elements serve to recruit the
protein subunits to the DNA, but that one of them
then scans along the chromosome, leaving its site
behind, until it encounters its cognate partner. Fa-
cilitated tracking combines elements of tracking and
looping, in that the distant site is brought along
with its binding protein. In a linking model, the two
subunits and their sites remain separate and other
proteins (shown in green) connect them. The previ-
ously known Tbox protein structures shown in A are
either monomeric or bind contiguous DNA elements
and consequently would not be expected to act at a
distance as depicted in these models.














identical to that of the Xbra dimer and the overall structures of
the two protein–DNA complexes strongly resemble each other
(Fig. 1A). Furthermore, dimers seen in the published Tbox crystal
structures require a palindromic DNA sequence to form, but only
nonpalindromic half sites have been found in the promoters of
target genes (23), which further call into question the physiological
relevance of these weak dimers.
The TBX5 structure is the first to be reported of a Tbox do-
main in both the bound and unbound states. Both structures are
similar, but a 310-helix at the C terminus of the TBX5 Tbox do-
main only forms upon DNA binding and is unstructured in the
DNA-unbound form (21). TBX5 is a monomer in solution and
binds as a monomer to the single consensus sequence present in
its DNA complex; how it would bind if presented with a palin-
dromic sequence is unknown.
All four Tbox proteins recognize DNA in the same way, by
means of two contiguous C-terminal helices: an α-helix and the
310-helix (Fig. 1A). Only a small number of amino acids make
direct contact with the bases in the minor groove of the DNA,
and these are conserved among Tbox family members (18),
explaining the consensus recognition sequence.
Tbox proteins can function as transcriptional activators and as
repressors. Which activity occurs for any given target gene has
been shown to depend on sequences located in the carboxyl-
terminal portion of the protein, outside the Tbox DNA binding
domain.
Enhancer sequences for some of the Tbox proteins have been
identified; these typically lie hundreds to thousands of base pairs
from the promoter site. For example, an enhancer sequence for
T-bet activation of the IFN-γ promoter is located ∼22 kb up-
stream of the promoter site and contains a consensus Tbox
binding sequence (24). Tbox enhancer sequences are very similar
in sequence to the promoter recognition sequences (25), sug-
gesting that the Tbox DBD binds directly to them; this has been
demonstrated directly in some cases. Although thus far only
single consensus sequence sites have been identified in natural
promoters of Tbox target genes, further calling into question the
relevance of the palindromic sites used in some of the crystal-
lographic studies and in many in vitro binding experiments, a few
of the enhancer sites do contain imperfect tandem recognition
elements; the significance of this is unclear.
The great separation between enhancer and promoter sites
bound by the same DBD raises the question of action at a dis-
tance, a problem that is particularly relevant for master regula-
tors of gene expression, which coordinately control the expression
of multiple genes. To date, four different—but not mutually
exclusive—hypotheses have been put forward for how an enhancer
activates its cognate genes across distances up to 800 kb (Fig. 1B)
(26): (i) Chromatin looping between the enhancer and promoters,
in which two protein molecules, which may be different or iden-
tical, bind to the separate elements and then form either a hetero-
or homodimer, bringing the distant sites into juxtaposition (27).
(ii) A tracking or scanning model, which hypothesizes that the
transcription-activating protein recruited by an enhancer linearly
tracks along chromatin until it encounters a competent promoter
with its own bound transcription factor and a dimer is formed
(28); in this model, the enhancer element is left behind and the
scanning process does not alter the proximity between the
enhancer and the promoter. Early evidence for tracking was
first presented at T4 late promoters by Herendeen et al. (29).
(iii) Facilitated tracking, which incorporates aspects of both
the looping and tracking models (30), where both the enhancer
element and its bound protein migrate along the chromatin fi-
ber until they encounter the cognate promoter complex, and the
intervening chromatin between the enhancer and the promoter
“reels out” through the enhancer complex and forms a loop,
which is progressively enlarged during tracking. (iv) A linking
model, which postulates that the binding of facilitator proteins
between an enhancer–protein complex and its cognate promoter–
protein complex mediates transcription-enhancing activity, with-
out bringing the two sites into juxtaposition (31).
Although studies of several multigene clusters, such as the
β-globin gene cluster, have shown that gene activation by, for ex-
ample, a remote enhancer can be associated with chromatin
looping (32, 33), the molecular mechanism of loop formation
and its involvement in gene regulation are not fully understood.
Recent evidence for the coordinate regulation of multiple genes,
sometimes even located on distinct chromosomes, in “transcription
factories” has pointed out the importance of understanding how
action at a distance occurs (34): for example, the IL-4 gene locus
was shown to associate with the IFN-γ gene locus on a different
chromosome in naive T cells that are committed to differentiate
into cells expressing only one of the two cytokines in a monoallelic
manner (35).
To gain insight into the nature of transcription control by the
master regulator T-bet, we crystallized its Tbox domain in
complex with a 24-bp DNA oligomer containing two consensus
binding sequences arranged palindromically. The crystal struc-
ture shows two Tbox monomers forming a tight dimer that is
completely different from the quaternary structure observed for
other Tbox proteins. Each monomer of the T-bet dimer binds a
single recognition site on two independent DNA double helical
oligomers; the second site of each palindrome is unoccupied.
The structure immediately suggests that the dimeric T-bet DBD
is capable of looping DNA by recognizing two distant sites
simultaneously. Size-exclusion chromatography confirms that
T-bet DBD dimers exist, and a FRET experiment demonstrates
that T-bet is able to synapse two independent pieces of DNA in
solution. Furthermore, in vitro and in vivo chromosome con-
formation capture (3C) experiments establish that T-bet func-
tions in the direct formation of chromatin loops or tethers at the
IFN-γ gene locus. Taken together, our data provide multiple
independent lines of evidence that T-bet is able to recognize
remote distal regulatory sequences and coordinate the expres-
sion of multiple genes simultaneously, at least in part by using its
unique dimeric structure to bring distant recognition elements
into juxtaposition.
Results
Structure Determination of the T-bet DBD–DNA Complex. Expression
of Mus musculus full-length T-bet in Escherichia coli resulted in
inclusion bodies. Better results were obtained with the T-bet
Tbox DNA binding domain (amino acids 135–326; T-bet DBD).
Although the domain on its own failed to crystallize, trials in-
cluding various length oligonucleotides representing consensus
or specific T-bet DNA binding sequences produced diffraction-
quality crystals. The best results were obtained with the full Tbox
domain and a 24-bp, palindromic, consensus T-bet recognition
sequence (the two core recognition elements are underlined):
AATTTCACACCTAGGTGTGAAATT
TTAAAGTGTGGATCCACACTTTAA
However, these crystals initially diffracted only to about 4-Å
resolution, even with synchrotron radiation. After optimizing the
buffer conditions for purification and the crystallization condi-
tions, crystals were finally obtained that diffracted to around 3-Å
resolution. The crystals had the symmetry of the hexagonal space
group P61 with unit cell dimensions a = b = 70.45 Å, c = 438.4 Å.
Packing considerations suggested that the asymmetric unit prob-
ably contained two Tbox domains and two DNA duplexes, but
a protein:palindromic-DNA stoichiometry of 2:1 was also
possible, and would be expected for a Tbox:DNA complex
such as that observed (Fig. 1A) in the crystal structures of the
transcription factors Xbra (19), TBX3 (20), and TBX1 (22).
The T-bet DBD structure (PDB ID code 5T1J) was solved by
molecular replacement using the known structure of B-form DNA
and a homology model of the T-bet DBDmonomer generated with
SWISS MODEL (36) based on the Tbox DNA binding domain of
the Brachyury/Xbra transcription factor (PDB ID code 1XBR),
which is 50% identical in sequence to the T-bet DBD. Following
model adjustment, the structure was refined by conventional
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means. The current Rcryst and Rfree are 26% and 30%, respec-
tively, using all data to 2.95-Å resolution (although data beyond
3.2 Å are weak), and the rmsd from ideal bond lengths and
angles are 0.004 Å and 0.9°, respectively. Details of the struc-
ture determination and statistics are given in SI Appendix,
Supplemental Methods and Materials and SI Appendix, Table S1.
The Structure of the T-bet DBD Monomer and Its Interactions with
DNA Are Typical of Other Tbox Domains. The asymmetric unit of the
crystal structure of the T-bet DBD comprises two monomers in
tight association (Fig. 2A). The polypeptide chain folds of the
two subunits of this T-bet DBD dimer are virtually identical to
one another, and are extremely similar to the canonical Tbox
fold first seen in the Xbra and TBX3 structures (19, 20). Each
subunit uses its two projecting helices to recognize the DNA
consensus sequence in the same way observed in all four previ-
ously determined Tbox protein structures, in agreement with the
known ability of T-bet to bind to the same sequences as TBX1,
TBX3, TBX5, and Xbra. The C-terminal α-helix of T-bet inserts
into the minor groove of the DNA, parallel to the axis of the
double helix, and the 310 helix, which is approximately perpen-
dicular to the α-helix, lies across the minor groove (Fig. 2A).
Recognition of the consensus sequence involves very few specific
contacts with the base pairs or sugars: the side-chain of Arg164
forms a hydrogen bond to the guanine base at position 17 in the
complementary strand of the consensus sequence, and phenyl-
alanines 320 and 324 partially wedge themselves between the
strands of the oligonucleotide, where they make nonbonded
contacts primarily with the ribose groups of guanine 15 and
thymine 16, respectively. Nearly all other contacts are with the
phosphate groups of the double helices: the side-chains of
Arg198, Ser262, Asn246, and Glu326, and the backbone NH of
Gly323 make hydrogen bonds to phosphate groups on the con-




XBRA (415 Å2)  TBX3 (370 Å2)  
T-bet (2478 Å2)  
     Antigen-antibody 18 1660
     Protease-inhibitor 23 1900
     Signal transduction 11 2500
     Miscellaneous 18 1870
     All 70 1900
Electron-transfer complexes 10 1190
Homodimers 122 3900
Crystal packing
     All interfaces 1320 570
     Large interfaces 188 1510
Protein-DNA complexes 65 3180
Data from Janin et al., 2007 (37)
Fig. 2. The DNA binding domain of T-bet forms a dimer that cross-links two independent DNA strands. (A) The two T-bet DBD monomers (light blue and
brown) form a tight dimer. Each monomer binds a single T-bet recognition site on a separate strand of DNA. The protruding helices that make contact with
the minor groove of the DNA are shown in red for the light blue monomer; the residues on the double helix that interact with this part of the Tbox domain
are shown in navy blue. (B) The T-bet DBD–DNA complex with the molecular surface overlaid, and a similar surface model of the Tbox DBD–DNA complexes of
Xbra and TBX3. The Xbra dimer interface is much smaller, and TBX3 binds essentially as two monomers. (C) Orthogonal views of the T-bet Tbox–DNA complex
showing binding of two independent DNA strands to each subunit of the dimer. The view on the right has a surface representation overlaid, indicating the
tightness of the complex.














Asn318, and Lys243 make hydrogen bonds with phosphates on the
complementary strand.
The DNA Double Helix Is Slightly Distorted by T-bet. The best fit of
the electron density in the region of DNA where the T-bet DBD
makes contact with the double helix could not be obtained with a
classic B-DNA conformation. At our resolution the nature of the
distortion cannot be characterized with precision, but it appears
similar to that in the TBX5–DNA complex (21). In that struc-
ture, the minor groove in the TBX5–DNA-binding site is wider
at base pairs 4–6 of the consensus sequence compared with
B-DNA, because of the insertion of the Tbox 310-helix into the
groove. Specifically, two aromatic residues, Phe232 and Phe236
in the TBX5 sequence, distort the DNA by nonpolar, steric in-
teractions. As noted above, the corresponding residues in T-bet
(Phe320 and Phe324) appear to do the same thing to the same
region of the consensus sequence in our structure. The TBX5–
DNA structure also shows a slight bending of the DNA at base
pairs 7 and 8. Our electron density in this region is consistent
with a similar distortion.
The T-bet DBD Forms a Dimer That Recognizes Two Independent
Pieces of DNA. The striking difference between the T-bet DBD–
DNA structure and the structures of DNA complexes of the
Tbox DBDs from TBX1, TBX3, TBX5, and Brachyury/Xbra, is
that the T-bet DBD forms a unique, very tight dimer that binds
to single half-sites of two independent double-stranded pal-
indromic molecules of DNA, rather than forming a weaker
dimer bound to two adjacent half sites on a single palindromic
DNA strand as in the Xbra structure, or simply binding as
nonassociating monomers to adjacent half-sites, as observed
in the TBX3–DNA, TBX5–DNA, and TBX1–DNA complexes
(Figs. 1A and 2).
The dimer interface in the T-bet DBD is very different from
that of the Xbra Tbox dimer in terms of both size and location of
the contact regions. The total surface area buried in the T-bet dimer
is about 2,478 Å2, compared with only 415 Å2 in the Xbra dimer
(Fig. 2B). This much greater contact area for the T-bet dimer is
characteristic of specific, physiologically relevant interactions (37).
We conclude, therefore, that in contrast to other Tbox tran-
scription factors, which appear to be monomeric in solution, T-bet
should be able to exist as a homodimer, and will be unlikely to
form heterodimers with other Tbox protein DBDs.
The Xbra Tbox dimer is primarily held together by interac-
tions at the “fingertips” of the extended domain structure, as
shown in Figs. 1A and 2B. This minimal contact keeps the rest of
the protein structure in each subunit well separated, and makes
the binding regions of the two subunits colinear, allowing both
monomers to bind to the same face of the two-turn palindromic
DNA sequence. In contrast, the T-bet dimer has extensive con-
tact between the sides of the fingers, orienting the two subunits
such that it is impossible for them to bind simultaneously to both
sites on a palindromic sequence (Fig. 2C). Instead, the second
subunit is splayed away from the DNA binding site of the first,
and their binding sites are parallel, allowing the second subunit
to bind to a different, remote recognition sequence on the same
(or possibly even a different) chromosome (Fig. 2C). The actual
interactions between the DNA and the recognition helices in the
subunit are, as indicated above, the same as those of the other Tbox
proteins (not surprisingly, because all those residues are conserved);
it is the different manner of oligomerization that causes one dimeric
molecule of T-bet to bind to two half sites on two different rec-
ognition sequences, unlike the other Tbox domains.
The T-bet DBD is able to form this unique dimer because
T-bet has two loops (loop 1, residues 248–256 in the full-length
T-bet sequence; loop 2, residues 276–293) that are different in
length and in sequence than the analogous loops in the other
Tbox proteins (SI Appendix, Fig. S3). These two loops largely
make up the new dimer interface, where they extend out like two
arms reaching to the adjacent monomer to form an interlocking
“hug.” Although these loops and their flanking residues are not
conserved in other Tbox proteins (and which is also why heterodimer
formation of T-bet with those proteins is unlikely), they are con-
served in all T-bet protein sequences determined to date. Loop 2
in particular has several negatively charged residues, which in-
teract with positively charged ones on its own monomer and on
the twofold-related monomer. The result is a conserved network
of salt-bridges and long-range electrostatic interactions that sta-
bilize the unique T-bet dimer (SI Appendix, Fig. S3C).
The Crystal Structure Suggests That T-bet Can Loop and Synapse DNA.
The structure provides direct evidence that a single dimeric
molecule of a eukaryotic transcriptional factor can bind simul-
taneously to two independent double-stranded DNA molecules.
A similar synapsing of independent DNA molecules by a dimeric
protein involved in recombination was observed in the crystal
structure of the complex of the RAG1 nonamer binding domain
with its nonamer DNA recognition site (38). Coincidentally the
functional counterpart of T-bet, GATA3, which is a master tran-
scriptional regulator that coordinately regulates the expression of
TH2 cytokines and represses the expression of TH1 cytokines, has
also been suggested to mediate long-range DNA interactions (39).
The implication of this mode of DNA binding is that one T-bet
dimer has the potential to juxtapose distant DNA sequences on
the same chromosome and, in the process, loop out the intervening
DNA (SI Appendix, Fig. S4), or that it could bind simultaneously to
sequences on two different chromosomes, thereby synapsing them,
as has been proposed for transcription factories (34, 35).
An extensively studied transcription factor that has been
shown to involve both DNA looping and interchromosomal
tethering is the CCCTC-binding factor, although its direct me-
chanical involvement in the process is uncertain (40). Coinci-
dentally, similar to T-bet, CTCF can act either as an activator or
a suppressor of various genes (40). CTCF physically binds to itself
to form homodimers (41), which causes the bound DNA to form
loops (42). Using ChIP followed by ChIP-seq, it was found that
CTCF localizes with cohesin genome-wide and affects gene reg-
ulatory mechanisms and higher-order chromatin structure (43).
We cannot distinguish between a looping model and a facili-
tated tracking model (Fig. 1B), which are variations of the same
theme, because both would result in a dimeric species bound to
two separate recognition sequences with a loop of DNA in be-
tween. For convenience, we will refer to both of these models
as “looping.”
T-bet Homodimerizes in Solution. If the function of T-bet involves
binding of a single dimeric T-bet molecule to two independent
DNA sites, T-bet must be able to homodimerize in solution, in
contrast to the other Tbox DNA binding proteins, which are
solution monomers. To assess the oligomerization state of T-bet,
we performed size-exclusion chromatography on the purified
T-bet Tbox domain in the absence of DNA. The results (Fig. 3)
clearly show a mixture of monomer and homodimer in solution
with a molecular mass of 22,707 kDa and 42,838 kDa respec-
tively. This matched well with the expected molecular mass for
the T-bet DNA binding domain of the monomer and homodimer
of 22,015 kDa and 44,030 kDa respectively.
T-bet Can Synapse DNA in Solution. We next devised an assay to
determine whether a single molecule of T-bet could bind si-
multaneously to two different DNA double helices in solution.
Following Yin et al. (38), we prepared two DNA oligomers, each
labeled at both ends with a donor fluorophore or an acceptor
fluorophore, where the donor emission spectrum overlaps with
the acceptor excitation spectrum (SI Appendix, Fig. S5). In the ab-
sence of T-bet, these independent constructs should display no
FRET between their fluorophores; however, if each binds to one
T-bet subunit in the manner observed in our structure, the donor-to-
acceptor distance would become less than 40 Å and a significant
FRET signal should be observable.
The two fluorescently labeled DNA oligomers gave no FRET
signal on their own or when mixed together. Addition of BSA or
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the LexA DNA binding protein, which binds as a homodimer to
two adjacent target sequences on the same DNA strand (44),
also failed to produce a signal. However, when a purified T-bet
Tbox domain was added to the mixture of oligonucleotides, a
strong T-bet concentration-dependent FRET signal was ob-
served (Fig. 4).
As a further test, we carried out the same assay with different
control proteins, including the T-bet homolog TBX5 [a generous
gift of Christoph Muller and Christian Stirnimann, Structural
and Computational Biology Unit, European Molecular Biology
Laboratory (EMBL) Heidelberg, Heidelberg], which binds to
the same consensus oligonucleotide sequence as T-bet. TBX5
has been shown to be a monomer both in solution and when
bound to DNA (21), and so would not be expected to produce
a FRET signal in this assay. Again, we only observed energy
transfer when T-bet was present in the oligonucleotide mix-
ture; neither other control proteins nor TBX5 gave any signal
(Fig. 4C).
We observed that the fluorescence of the acceptor-DNA used
in the FRET assay [carboxytetramethylrhodamine (TAMRA)-
DNA] was quenched upon binding to T-bet independent of the
donor-DNA [6-carboxyfluorescein (FAM)-DNA]. We used this
non-FRET effect as a binding assay to determine the Kd for the
T-bet consensus sequence complex by titrating T-bet Tbox pro-
tein to TAMRA-DNA and monitoring the non-FRET quenching
of TAMRA-DNA fluorescence. The Tbox domain of T-bet has a
relatively high affinity for its recognition site; the measured Kd is
∼19 nM (Fig. 4D).
Dissociation Kinetics of the T-bet–DNA Complex.We used the loss of
fluorescence quenching on dissociation of the T-bet/FAM-DNA/
TAMRA-DNA complex and the T-bet/TAMRA-DNA complex
upon addition of excess unlabeled DNA and dilution to deter-
mine the kinetic dissociation parameters (SI Appendix, Fig. S6).
Two different fluorescence signals were used to capture the
dissociation process. The loss of TAMRA-DNA fluorescence
quenching captures the dissociation of total bound DNA to
T-bet, whereas the loss of FAM-DNA fluorescence quenching in
the presence of TAMRA-DNA captures the initial dissociation
step that corresponds to either the dissociation of the first double
helix or the dissociation into monomers of DNA-bound T-bet
dimer (i.e., the loss of FRET step). The dissociation kinetics
were biphasic as detected by the loss of TAMRA-DNA fluo-
rescence quenching, with a fast dissociation rate constant koff(fast)
of 5.0 × 10−3 s−1 and a slow dissociation rate constant [koff(slow)]
of 0.28 × 10−3 s−1, but monophasic when detected by the loss of
FAM-DNA fluorescence quenching (loss of the FRET signal),
with a dissociation rate constant of 2.5 × 10−3 s−1. Taken together,
the dissociation kinetics data suggest that the dissociation of the
T-bet–DNA quaternary complex must occur via a minimum of two
steps and that the fast dissociation rate constant corresponds to
the initial step that leads to the loss of FRET signal.
Two simple schemes consistent with these observations are
shown in SI Appendix, Fig. S7. In model 1, the T-bet dimer dis-
sociates first, followed by dissociation of the DNA from the
monomers. Model 2 starts with the dissociation of one DNA
oligomer from the dimer, followed by dissociation of the other
oligomer. Model 1 may be preferred because it does not require
different dissociating rate constants for the two oligonucleotides
to the protein; in this model the fast step is dimer dissociation
and both monomers lose their DNA at the same rate. The two
models can be used to predict the concentration dependence of
the FRET signal observed when T-bet binds to DNA (SI Ap-
pendix, Fig. S8A). Comparison with our FRET measurements
suggests that model 1 is a better fit to the observed data (SI
Appendix, Fig. S8 B and C), although a mixture of both models
may be possible. Assuming primarily model 1, T-bet appears
able to bind to DNA first as a pair of independent monomers,
followed by protein dimerization to bring the two DNA sites
together (49).
T-bet Directly Mediates Long-Range DNA Interactions at the IFN-γ
Gene Locus. To assess if T-bet mediates long-range DNA inter-
actions by direct juxtaposition of distant DNA regions in cis to
form DNA loops, we measured long-range DNA interactions
within one of T-bet’s physiological substrates, the IFN-γ gene
locus, by using an in vitro 3C assay on samples containing puri-
fied T-bet DBD and a BAC plasmid containing the IFN-γ gene
locus (45). The IFN-γ gene is a hallmark TH1 cytokine gene
activated by T-bet, and conserved noncoding sequences (CNS)
far upstream of the IFN-γ gene are known to physically interact
with T-bet and to enhance transcription of IFN-γ in a T-bet–
dependent manner (24, 46) (Fig. 5A). We therefore sought to
determine if the proximal promoter of IFN-γ physically interacts
with these distal CNS enhancer sites in a T-bet–dependent
manner, forming DNA loops (data in SI Appendix, Fig. S9). As
shown in Fig. 5B, the in vitro 3C profiles showed that the IFN-γ
promoter region interacts with CNS-22, CNS-34, or CNS-55
fragments (the numbers refer to their locations upstream from
the promoter in kilobases) only in the presence of the T-bet
DBD. These interactions were absent when T-bet was omitted
and replaced with a nonphysiologically relevant protein BSA.
Interaction of the promoter fragment with the CNS-22 fragment
was the strongest, which coincides with the finding that this CNS
is the strongest known T-bet–dependent enhancer of IFN-γ
transcription (24). Taken together, our in vitro 3C experiment
clearly shows that the T-bet DBD, in the absence any other
protein or protein complexes, is sufficient for the direct media-
tion of long-range DNA interactions in the IFN-γ gene locus.
To further assess T-bet mediation of direct loop formation, we
also performed standard in vivo 3C on mouse CD4+ T-cells har-
vested and expanded in vitro from either T-bet+/+ wild-type or
T-bet−/− knockout mice. As shown in Fig. 5C, a strong DNA
looping interaction was observed between the promoter fragment
and the CNS-22 fragment in both T-bet+/+ and T-bet−/− samples,
although the interaction frequency was higher in the T-bet+/+
sample. The fact that nearly identical DNA interaction profiles at
the IFN-γ locus were observed in both T-bet+/+ and T-bet−/−
mouse T-cells implies that these 3C fragment interactions were at
least partially formed independent of T-bet, presumably by other
unidentified protein complexes that “prime” the TH1 gene cluster.
This result suggests a model for the physiological role of T-bet
DNA looping activity consistent with the observed in vivo and in
vitro 3C data (Fig. 6). As shown in Fig. 6A, a plausible physio-
logical role of T-bet may be to stabilize and maintain existing
loops formed between distant transcription regulatory elements
by other protein complexes; in this model, no new long-range
DNA interactions need be formed by T-bet, but efficient tran-
scription requires stabilization of previously synapsed or “primed”
Fig. 3. The DNA binding domain of T-bet forms a dimer in solution. Size-
exclusion chromatography data show that T-bet DBD exists as a mixture of
monomeric and dimeric species in solution.














DNA regions by T-bet. This model is consistent with the finding
that transcription of β-globin genes requires long contact times
between the β-globin–locus control region and β-globin gene, in
the range of 45–80 min (47): based on our dissociation kinetic
studies of the T-bet–DNA complex (SI Appendix, Fig. S6), the
overall mean lifetime of dimeric T-bet bound to DNA is
∼60 min, indicating that T-bet is capable of stabilizing long-range
DNA interactions in the time range of 45–80 min in vivo. We
note that Splinter et al. (48) have found that CTCF binds sites
around the mouse β-globin locus that spatially cluster in the
erythroid cell nucleus, and showed that both conditional deletion
of CTCF and targeted disruption of its DNA-binding site de-
stabilize these long-range interactions and cause local loss of
histone acetylation and gain of histone methylation, but without
affecting transcription at the locus. These data show that CTCF
is directly involved in chromatin architecture and regulates lo-
cal balance between active and repressive chromatin marks, and
Splinter et al. further postulate that throughout the genome,
relative position and stability of CTCF-mediated loops determine
their effect on enhancer–promoter interactions, with gene insu-
lation as one possible outcome. CTCF or a similar protein could
thus preform the appropriate loops without activating transcrip-
tion until T-bet binds and the loops are stabilized and the rest of
the transcriptional machinery is brought to bear.
A second plausible model consistent with the in vivo 3C data
suggests that the physiological role of T-bet is indeed to initiate
de novo, new long-range DNA interactions that bring distal
enhancers into close proximity to the promoter, but these T-bet–
dependent loops nearly coincide with T-bet–independent loops
formed within the same 3C DNA fragments (Fig. 6B). Again, a
protein like CTCF could establish these less-specific loops. Be-
cause of the limiting resolution of the 3C assay, where some of
the digested DNA fragments were in the multiple thousands of
base pairs long, such T-bet–mediated loops may not have been
uniquely resolved from T-bet–independent loops. Both models
would be consistent with an additional role for T-bet as a master
regulator of cell fate, that of bringing previously looped en-
hancer–promoter “hubs” from different genes together (49).
Discussion
T-bet Has a Unique Quaternary Structure Enabling It to Bind Two
Distinct DNA Sites. T-bet (also called TBX21) is a member of the
Tbox family of eukaryotic transcription factors, whose proteins
regulate key processes in development (2). T-bet expression dur-
ing T-cell activation is strongly dependent on IFN-γ signaling and
STAT1 activation (50). A genomic map of T-bet binding in pri-
mary human T cells showed that, in TH1 cells, T-bet associates
with genes of diverse function, including those with roles in
transcriptional regulation, chemotaxis, and adhesion, whereas the
TH2-specific transcription factor GATA-3 shares a large propor-
tion of targets with T-bet (51). The choice between TH1 and TH2
lineage commitment appears to be the result of the opposing
action of these two master regulators, T-bet and GATA-3, at a
shared set of target genes.
In contrast to other Tbox proteins, T-bet expression is suffi-
cient to reprogram a fully differentiated TH2 cell into a TH1 cell
(7). Nevertheless, the DNA binding domain of T-bet has been
assumed to be similar in structure to other Tbox domains, and to
recognize the Tbox family consensus DNA sequence in the
same way.
Although the crystal structure of the Xbra–DNA complex
showed a Tbox homodimer binding to both sites on a single
palindromic recognition element (19), the interface between the
monomers is so small that it is unlikely to persist in solution.
Consistent with this hypothesis, the structure of the related
TBX3–DNA and TBX1–DNA complexes showed almost no
association between the monomers—although they each bound
to a half-site of the palindrome in essentially the same manner
as Xbra (20)—and TBX5, another Tbox family transcriptional
regulator, was shown to be monomeric both when bound to
DNA in the crystal structure of the complex, and in solution (21).
It seems likely, therefore, that most members of the Tbox family
are monomers and act by binding as monomers to single rec-
ognition sequences (half-sites of the palindromic constructs).
This generalization is borne out by the observation that most
Tbox binding sites identified to date, whether in promoter re-
gions or other distal regulatory elements, are not palindromic
and consist only of a single recognition sequence (18).
The structure of the T-bet Tbox domain in complex with DNA
presented here shows that this particular Tbox family member is
a striking exception. Because of sequence differences with all
other known Tbox proteins in two loop regions distal to the
DNA binding site, T-bet forms a homodimer with an extensive
interface. This quaternary structure makes it impossible for a
single dimeric molecule of T-bet to bind a palindromic double
site, but instead enables the dimer to bind to two separate single































Kd ~ 19 nM
Fig. 4. FRET experiments confirm T-bet can synapse
DNA in vitro. (A) Titration of FAM- and TAMRA-labeled
DNA with T-bet. A strong FRET signal is observed
when T-bet is present together with both donor- and
acceptor-labeled DNA, but not in the absence of T-bet.
(B) Relative FRET efficiency vs. T-bet concentration.
(C) Fluorescently labeled DNA FRET efficiency induced
by T-bet, TBX5, lysozyme, BSA, and buffer using 10 nM
FAM-labeled DNA and 10 nM TAMRA-labeled DNA.
Only T-bet produced a FRET signal. Even the mono-
meric T-bet homolog TBX5, which binds to the same
consensus sequence, fails to do so. The concentrations
of T-bet, TBX5, lysozyme, and BSA used in this exper-
iment were 1.16 mM, 3.75 mM, 5.35 mM, and 2.5 mM,
respectively. (D) The binding affinity of DNA to T-bet
was determined by titrating T-bet to 1.25 nM TAMRA-
DNA and observing the non-FRET decrease in the
fluorescence of the T-bet bound TAMRA-DNA (SI
Appendix, Supplementary Methods and Materials).
The dissociation constant determined by this method
was ∼19 nM.
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recognition elements, which could be located thousands of base
pairs apart or even on different chromosomes. Size-exclusion
chromatography confirmed that the Tbox domain of T-bet forms
dimers in vitro. The subunit interface region of the T-bet dimer
may represent a target for small molecules aimed at either inhibiting
T-bet function by disrupting the dimer or increasing the steady-state
level of the active form of the protein by stabilizing the association
between the monomers.
To test the hypothesis from the crystal structure that a single
dimer of T-bet is able to juxtapose distant or disconnected DNA
sites, we devised a FRET assay and showed that T-bet could
bring two independent recognition sequences together, whereas
the monomeric TBX5 protein could not. We were also able to
measure the dissociation constant of the T-bet–DNA complex,
which was found to be about 19 nM. Furthermore, we also de-
vised 3C assays to explore the architectural role of T-bet on the
IFN-γ gene locus and showed in vitro that T-bet alone is suffi-
cient for the direct formation of chromatin loops or tethers that
bring about the juxtaposition of IFN-γ promoter and distal en-
hancer DNA fragments, which is consistent with our crystal
structure. Similar 3C assays performed in vivo showed that
similar loops existed in cells in the absence of T-bet but were
stabilized in its presence (see below).
A Model for Simultaneous Regulation of Multiple Genetic Loci by
T-bet. As a master regulator of TH1 lineage commitment, T-bet
binds to consensus recognition sites in the promoter region of
numerous genes, where it activates the expression of TH1-spe-
cific genes while simultaneously repressing transcription of TH2-
specific genes. Its regulatory properties also involve enhancer
elements with similar sequences to the promoter sites, suggesting
that the Tbox domain of T-bet binds to those loci as well.
A DNA looping model has been proposed to account for the
transcription activation properties of noncoding enhancer DNA
regions that are >3 kb away from the promoter region of a gene
(26, 31). In such a model, a gene is activated when a distal en-
hancer region is brought into close proximity to the promoter
region by DNA looping or facilitated tracking, because each site
is bound to one subunit of an oligomeric transcription factor
(Fig. 1B). Other protein and protein–DNA complexes important
for transcription that are located far away from a gene can also
be brought to the promoter by a DNA-synapsing transcription
factor if they bind at or near sequences recognized by that DNA
binding protein (34, 35).
Our structure of the T-bet DBD suggests that it has DNA
looping activity, and the FRET and in vitro 3C experiments
confirm that this activity is present for the isolated Tbox domain




Fig. 5. The 3C experiments show T-bet can synapse IFN-γ (Ifn-γ) enhancer and promoter sites. (A) VISTA plot comparing human and mouse sequences at the
Ifng gene locus. Locations of CNS are highlighted in pink. These CNS sites are also conserved in rhesus, dog, horse, and rat. CNS-55, CNS-34, CNS-22, CNS-5, and
the Ifng promoter are known to bind to T-bet as determined by ChIP (24). (B) In vitro 3C profiles of samples with T-bet (T-bet DBD) or without T-bet (BSA).
(C) In vivo 3C profiles of samples with T-bet (WT mouse CD4+ T-cells) or without T-bet (T-bet−/−mouse CD4+ T-cells). In B and C, horizontal bars directly above
the x axis depict the length and location of each 3C fragments analyzed. The promoter fragment, shown as a red bar, was used as the 3C anchor for both the
in vitro and in vivo 3C experiments.














model in which a single T-bet dimer is able to bind simulta-
neously to recognition sites on two different chromosomal re-
gions (Fig. 6C). One site, for example, could be a promoter
recognition sequence, whereas the other could be either a distal
enhancer site or a promoter recognition sequence on a com-
pletely different gene. In principle, that gene need not be lo-
cated on the same chromosome as the first one, allowing T-bet to
initiate the formation or stabilization of so-called transcriptional
factories that coordinately regulate different genes regardless of
their location (49). Depending on the function of the N- and
C-terminal domains of T-bet and the various other proteins that
are known to bind to them, including other transcription factors,
such as GATA-3 (51), factories involving a number of different
genes could coalesce around multiple transcription factors, all
nucleated by, for example, one or more T-bet dimers to form an
active chromatin hub. It is also not necessary that transcription of
all genes in such a factory be activated, depending again, on what
else is bound to its other domains, a single T-bet molecule could
both activate a gene and repress another simultaneously (Fig. 6C).
This model fits well with biochemical data on the transcrip-
tional regulation by T-bet of the IFN-γ locus. Recent studies
have identified multiple cis-regulatory elements within ∼110 kb
surrounding the IFN-γ locus, including enhancers and boundary
elements, many of which bind the Th1-specific transcription
factors T-bet and STAT4; moreover, CNSs greater than 5 kb
upstream and downstream of the IFN-γ gene were found to
enhance the transcription of IFN-γ in a T-bet–dependent man-
ner (3, 24, 25, 52–58). DNA colocalization assays, such as 3C,
have found that these CNS sites can colocalize with the promoter
region of the IFN-γ gene in vivo (59, 60, and present work). It
has also been found that the CNS sites, as well as the IFN-γ
promoter region, contain conserved Tbox binding half sites,
but not full palindromic sites, just as would be expected from
our model. It will be important to determine how the N- and
C-terminal domains of T-bet modulate its transcriptional ac-
tivity, and to assess its interactions with other protein complexes
known to facilitate enhancer–promoter association, such as the
general transcription factor mediator (61).
The crystal structure and the various in vitro biochemical and
biophysical data taken together strongly suggest that the DNA
binding domain of T-bet dimerizes to bring distal elements to-
gether to modulate transcription. As discussed, in light of the
small T-bet dependent “looping” effects observed in the in vivo
3C experiment in Th1 cells, a plausible physiological role of T-bet
consistent with all of the data is that T-bet may function to stabilize
and solidify existing loops performed by other “looping” transcrip-
tion factors, such as CTCF (or other components of the transcrip-
tional machinery) during T-cell differentiation. T-bet could also be
forming new loops within larger T-bet–independent loops that we
are not able to resolve with the 3C experiment. The resolution of
these ideas will be the basis of future experiments.
In summary, our T-bet DBD–DNA crystal structure, fluores-
cence binding assays, and 3C assays all indicate that T-bet func-
tions as a homodimer that activates the transcription of loci, such
as the IFN-γ gene via a DNA looping mechanism, and differs from
other Tbox transcription factors in its ability to bind to more than
one recognition sequence at the same time. Such activity may
underlie the particular potency of T-bet as a master regulator of
gene expression in the immune system (2) and may be a more
general characteristic of other transcription factors that are also
master regulators of cell-fate determination, such as FOXP3 (62)
and GATA3 (39), for which there are also crystallographic evi-
dence for synapsing of DNA.
Materials and Methods
Construction, expression, and purification of the T-bet DBD were done using
conventional cloning, expression, and purification methods. Purified T-bet
DBD in complex with a 24-bp palindromic DNA were crystallized by the
hanging-drop method. Crystallographic data were collected at the Advanced
Photon Source of Argonne National Laboratory, and the final structure was
solved by Molecular Replacement using a homology model generated from
the crystal structure of the Xenopus laevis Brachyury T-domain (PDB ID code
1XBR). Size-exclusion chromatography of T-bet DBD was carried out using an
YMC-Pack Diol-120 column on an Agilent HPLC system. Fluorescence DNA
binding and kinetic experiments were carried out using fluorescently tagged
DNA molecules. A traditional 3C assay was carried out as previously de-
scribed (45, 63). Long-range DNA interactions induced by the T-bet DBD




Fig. 6. Proposed models for the physiological role of
T-bet DNA looping activity based on the in vivo 3C
data. (A) T-bet functions to stabilize and maintain
existing DNA loops. No new long-range DNA inter-
actions are created. (B) T-bet creates new long-range
DNA interactions, but these new interactions were
not detected uniquely as T-bet–dependent interac-
tions because of the existence of prior T-bet–independent
interactions between the same 3C fragments. (C) Sche-
matic of T-bet molecules binding simultaneously to pro-
moter sites on genes located on different chromosomes,
activating one while repressing the other.
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In this modified 3C assay, purified T-bet DBD and purified naked DNA
containing the IFN-γ gene locus (BAC RP24-348011) were incubated together,
and DNA interactions induced by the addition of T-bet DBD were detected as
previously described in the original in vivo 3C assay (45, 63). Details of
all experimental procedures can be found in SI Appendix, Supplemental
Methods and Materials.
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